SS Innovations International, Inc. — Form 8-K
Filed October 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
This is a company presentation (not an 8-K event disclosure) containing operational snapshots as of September–October 2026. Key metrics: 244 SSi Mantra systems installed (cumulative); 14,503 surgeries performed; $42.5M revenue in 2025 (+106% YoY); 46% gross margin; net loss of $8.2M in 2025. Leadership: Founder/Chairman Dr. Sudhir Srivastava owns ~54% (108.6M shares); Dr. Frederic Moll owns ~10% (20.8M shares). No material transaction, financing, or corporate event is announced or disclosed in this presentation.
Why this rating
Routine investor presentation; no material corporate event, transaction, or disclosure. Operational metrics are backward-looking (through Sept 2026). No new deal, financing, or guidance change disclosed.
See more from October 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.